US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NanoViricides

0.9900

-0.0500-4.81%

Post-market: 1.000.0120+1.21%19:17 EDT

Volume:121.07K

Turnover:125.99K

Market Cap:15.49M

PE:-1.38

High:1.14

Open:1.14

Low:0.9800

Close:1.04

Loading ...

Overview Company News Filings

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

ACCESS Newswire

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

ACCESS Newswire

NanoViricides reports Q2 EPS (14c) vs. (18c) last year

NanoViricides, Inc. Has Filed its Quarterly Report

ACCESS Newswire

NanoViricides: Fiscal Q2 Earnings Snapshot

Associated Press Finance

Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In?

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

ACCESS Newswire

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

ACCESS Newswire

NanoViricides Inc: Engages Cro for Phase Ii Clinical Trial

THOMSON REUTERS

NanoViricides Engages CRO for Phase II Clinical Trial

ACCESS Newswire

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals

NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID

NanoViricides: Fiscal Q1 Earnings Snapshot

Associated Press Finance

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am

NanoViricides President Dr. Diwan to Present at the PODD Conference

NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology

NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NNVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NNVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","market":"US","secType":"STK","nameCN":"NanoViricides","latestPrice":0.99,"timestamp":1744142400000,"preClose":1.04,"halted":0,"volume":121074,"hourTrading":{"tag":"盘后","latestPrice":1.002,"preClose":0.99,"latestTime":"19:17 EDT","volume":737,"amount":733.7059785,"timestamp":1744154249694},"delay":0,"floatShares":15074310,"shares":15641611,"eps":-0.716455,"marketStatus":"Post-Market Trading","change":-0.05,"latestTime":"04-08 19:30:21 EDT","open":1.14,"high":1.14,"low":0.98,"amount":125987.7761826,"amplitude":0.153846,"askPrice":1.17,"askSize":200,"bidPrice":0.9054,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.716455,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1744156800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1380081600000,"exchange":"AMEX","adjPreClose":1.04,"preHourTrading":{"tag":"盘前","latestPrice":1.08,"preClose":1.04,"latestTime":"09:29 EDT","volume":802,"amount":851.0600242,"timestamp":1744118987505},"postHourTrading":{"tag":"盘后","latestPrice":1.002,"preClose":0.99,"latestTime":"19:17 EDT","volume":737,"amount":733.7059785,"timestamp":1744154249694},"volumeRatio":0.830654,"impliedVol":0.5404,"impliedVolPercentile":0.2749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","floatShares":15074310,"roa":"-47.69%","roe":"-82.01%","lyrEps":-0.698686,"volumeRatio":0.830654,"shares":15641611,"dividePrice":0,"high":1.14,"amplitude":0.153846,"preClose":1.04,"low":0.98,"week52Low":0.98,"pbRate":"1.49","week52High":3.59,"institutionHeld":0,"latestPrice":0.99,"committee":-0.333333,"eps":-0.716455,"divideRate":0,"volume":121074,"delay":0,"ttmEps":-0.716455,"open":1.14,"prevYearClose":1.43,"prevWeekClose":1.08,"prevMonthClose":1.17,"prevQuarterClose":1.17,"fiveDayClose":1.16,"twentyDayClose":1.29,"sixtyDayClose":1.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NNVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518147107","title":"NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2518147107","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518147107?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:30","pubTimestamp":1741689000,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. , a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its business is not affected by the tariff policies of the US government or corresponding retaliatory policies of other governments, nor is it affected by the spending cuts being implemented by the current White House administration.Therefore, the Company believes that smart financial strategists would view the longer term strong prospects of the Company  as supporting the case of NNVC as an effective hedge against the current general stock market turmoil.\"We believe that the policies of the current Secretary of HHS, Mr. Robert F. Kennedy, would lead to focusing more strongly on development of broad-spectrum antiviral treatments such as our clinical-stage as well as earlier-stage antiviral pipeline drug products rather than the previous vaccine-focused strategy,\" said Anil R. Diw","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-not-affected-tariffs-other-103000613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2516271126","title":"Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2516271126","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516271126?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:30","pubTimestamp":1741087800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled \"Measles outbreak is call to action for all of us\". He identifies an important issue that, \"…there is no approved antiviral for those who may be infected…\"We applaud Secretary Kennedy for recognizing the urgency of the situation and taking all possible steps including promoting vaccination in response to this outbreak, while clearly recognizing the deficiency in the response to be the lack of an effective treatment for measles viral disease,\" said Anil R. Diwan, PhD., President of NanoViricides, Inc.We note that the current efforts at containment with case-tracking, contact-tracing and isolation, face daunting challenges to be effective because measles is far more contagious than SARS-CoV-2 that caused the global COVID pandemic. In fact, measles is the most contagious disease known to humans. Also, a person may be contagious several days befo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/measles-outbreak-nv-387-promises-113000537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HHS","BK4568","BK4009","NNVC","BK4139"],"gpt_icon":0},{"id":"2512101445","title":"NanoViricides reports Q2 EPS (14c) vs. (18c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2512101445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512101445?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:50","pubTimestamp":1739969423,"startTime":"0","endTime":"0","summary":"The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 Million...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q2-eps-14c-vs-18c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q2-eps-14c-vs-18c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC"],"gpt_icon":0},{"id":"2512810520","title":"NanoViricides, Inc. Has Filed its Quarterly Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2512810520","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512810520?lang=en_us&edition=fundamental","pubTime":"2025-02-19 19:30","pubTimestamp":1739964600,"startTime":"0","endTime":"0","summary":"Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu. We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 Million. In addition, we reported approximately $7.17 Million in Net Property and Equipment (P&E) assets . The strong P&E assets comprise our cGMP-capable manufacturing and R&D facility in Shelton, CT. The total current liabilities were approximately $1.18 Million.The net cash utilized during the six months ended December 31, 2024 was approximately $4.79 million. This included certain non-recurring expenditures including R&D expenditures in preparation for a Phase II clinical trial application. We raised approximately $4 million net of commission and certain expenses in an At-the-Market offering  during the six months ended December 31, 2024.There is no drug available for the treatment of MPox infection. The MPox Clade 1/1b has a substantially g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-filed-quarterly-report-113000804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2511610418","title":"NanoViricides: Fiscal Q2 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2511610418","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511610418?lang=en_us&edition=fundamental","pubTime":"2025-02-15 05:37","pubTimestamp":1739569040,"startTime":"0","endTime":"0","summary":"SHELTON, Conn.  — SHELTON, Conn.  — NanoViricides Inc.  on Friday reported a loss of $2 million in its fiscal second quarter.On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 14 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-fiscal-q2-earnings-snapshot-213720728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC"],"gpt_icon":0},{"id":"2511645049","title":"Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511645049","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511645049?lang=en_us&edition=fundamental","pubTime":"2025-02-15 00:29","pubTimestamp":1739550576,"startTime":"0","endTime":"0","summary":"We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at where NanoViricides Inc.  stands against other best nanotech penny stocks to invest in.Nanotech involves working with tiny particles which are about the size of molecules. This field is being used to improve products in many different industries, like electronics, medicine, and energy. By manipulating matter at this tiny scale, materials and devices with special properties can be made. The global nanotech market was valued at $3.69 billion in 2022 and is projected to grow at a 33.1% CAGR from 2023 to 2030, as reported by Grand View Research. This is driven by the increased use in medical diagnostics and imaging, technological advancements, substantial R&D funding, and the creation of advanced materials for healthcare, electronics, aerospace, textiles, transportation, manufacturing, and agriculture.While the nanotech industry as a whole holds promise, it is still in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-nnvc-best-nanotech-162936380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2510097802","title":"NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape","url":"https://stock-news.laohu8.com/highlight/detail?id=2510097802","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510097802?lang=en_us&edition=fundamental","pubTime":"2025-02-11 19:30","pubTimestamp":1739273400,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc.   declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu virus H5N1 likely cannot escape despite its ability to mutate rapidly with genomic changes.An \"opinion and analysis\" article published in Scientific American on February 7th correctly recognizes that the H5N1 \"virus is versatile…This article's titular declaration that the \"US is not ready for bird flu in humans\" is myopic.We beg to differ from this opinion, and hereby declare that our broad-spectrum antiviral drug NV-387 that H5N1 virus will not be able to escape even as it changes in the field, is ready to fight the battle and save lives, should a human H5N1 pandemic occur.The bird-flu virus and its variants are highly unlikely to escape the broad spectrum, host-mimetic, antiviral drug NV-387, because all of these variants continue to land on the same host-side feature that ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-drug-fight-bird-flu-113000223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2507246684","title":"NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507246684","media":"ACCESS Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507246684?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:30","pubTimestamp":1738150200,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc.  , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ.NanoViricides Presentation at the MicroCap Conference, Atlantic City. NanoViricides is rapidly moving towards Phase II Safety, Tolerability and Efficacy Evaluation of its Lead Drug candidate, NV-387, for the Treatment of MPOX disease. The Company has announced that it has engaged a CRO for conducting the Phase II clinical trials in the African Region.The Phase II-ready drug NV-387 has demonstrated extremely broad antiviral spectrum of activity in animal models, which could prove to be as revolutionary for viral infections as penicillin was for bacterial infections. This broad spectrum is because NV-387 is designed to mimic a host-side feature that is used by over 90-95% of human pathogenic virus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-present-microcap-conference-wednesday-113000322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4568","NNVC"],"gpt_icon":0},{"id":"2506373936","title":"NanoViricides Inc: Engages Cro for Phase Ii Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2506373936","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506373936?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:34","pubTimestamp":1737977649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL08B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2506384376","title":"NanoViricides Engages CRO for Phase II Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2506384376","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506384376?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:30","pubTimestamp":1737977400,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc.   today announced that it has engaged a Clinical Research Organization  to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline.\"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases,\" said Anil R. Diwan, Ph.D., further commenting, \"Our regulatory development strategy for this drug is now further advancing into a Phase II clinical trial stage.\". The Company has previously stated that it is working towards a Phase II clinical trial to evaluate the effectiveness of NV-387 for the treatment of MPox patients. MPox disease, caused by the human Mpox virus  has been causing a regional pandemic encompassing several countries in the African region, including the Democratic Republic of Congo , Uganda, and others. It led to the WHO declar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-engages-cro-phase-ii-113000925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2503303375","title":"NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503303375","media":"ACCESSWIRE","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503303375?lang=en_us&edition=fundamental","pubTime":"2025-01-13 19:30","pubTimestamp":1736767800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc.  , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase 2025 in San Fransisco, being held in parallel to the JP Morgan Life Sciences Conference.The Phase II-ready drug NV-387 has demonstrated extremely broad antiviral spectrum of activity in animal models, which could prove to be as revolutionary for viral infections as penicillin was for bacterial infections. This broad spectrum is because NV-387 is designed to mimic a host-side feature that is used by over 90-95% of human pathogenic viruses when they cause infection.NV-387 has also shown strong activity in lethal animal model studies for MPox and Smallpox treatment developments. There is no drug for the treatment of MPox infection at present. MPox Clade 1 and 1b infections have caused a continuing pandemic in the Africa that led to WHO declaring a Public H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-present-biotech-showcase-san-113000907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2501728483","title":"Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals","url":"https://stock-news.laohu8.com/highlight/detail?id=2501728483","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501728483?lang=en_us&edition=fundamental","pubTime":"2025-01-08 19:30","pubTimestamp":1736335800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc.  , comments on the many viruses that could cause pandemics that are going around already.This season, two different genotypes of H5N1 bird flu, namely  the severe and lethal form D1.1 that has spread globally in birds, and  the less severe B3.13 genotype widely spread in diary cattle in North America are causing major concerns even as Seasonal Influenza cases abound.In addition to that, in the USA, and globally, there are significant numbers of cases of COVID-19, RSV, and hMPV as expected seasonally, that cause various respiratory syndromes from common colds to bronchitis to pneumonia. Norovirus, a primarily gastro-enteric infection that causes vomiting and severe diarrhea has surged up as well.All of these are RNA viruses that evolve rapidly in the field. All of these can develop resistance to vaccines, antibodies, and existing small chemical drugs  soon after they face such countermeasures i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/multiple-viral-threats-amplify-call-113000300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BNTX","BK4588","BK4551","LU2065732104.USD","BK4548","BK4585","NNVC","BK4018","BK4535","BK4139","BK4568","SPB"],"gpt_icon":0},{"id":"2483212733","title":"NanoViricides, Inc. Has Filed Its Quarterly Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include MPOX/Smallpox, RSV, Influenza, COVID","url":"https://stock-news.laohu8.com/highlight/detail?id=2483212733","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483212733?lang=en_us&edition=fundamental","pubTime":"2024-11-15 19:30","pubTimestamp":1731670200,"startTime":"0","endTime":"0","summary":"We reported that, as of September 30, 2024, we had cash and cash equivalent current assets balance of approximately $3.87 Million. In addition, we reported approximately $7.36 Million in Net Property and Equipment (P&E) assets . The strong P&E assets comprise our cGMP-capable manufacturing and R&D facility in Shelton, CT. The total current liabilities were approximately $1.63 Million. In comparison, as of June 30, 2024, we had cash and cash equivalent balance of approximately $4.8 Million, P&E assets of approximately $7.51 Million , and total current liabilities of approximately $1.36 Million.The net cash utilized in the reported period for operating activities was approximately $2.6 million that included certain non-recurring expenditures including R&D expenditures in preparation for a Phase II clinical trial application of approximately $1 million. We raised approximately $1.71 million net of commission and certain expenses in an At-the-Market offering  in the reported period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-filed-quarterly-report-113000500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2483680943","title":"NanoViricides: Fiscal Q1 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2483680943","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483680943?lang=en_us&edition=fundamental","pubTime":"2024-11-15 08:20","pubTimestamp":1731630014,"startTime":"0","endTime":"0","summary":"SHELTON, Conn.  — SHELTON, Conn.  — NanoViricides Inc.  on Thursday reported a loss of $3.1 million in its fiscal first quarter.On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 23 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-fiscal-q1-earnings-snapshot-002014506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC"],"gpt_icon":0},{"id":"2480287173","title":"NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am","url":"https://stock-news.laohu8.com/highlight/detail?id=2480287173","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480287173?lang=en_us&edition=fundamental","pubTime":"2024-11-04 13:00","pubTimestamp":1730696400,"startTime":"0","endTime":"0","summary":"Revolutionizing Antiviral Treatments, Phase 2-Ready, Broad-Spectrum Lead Drug NV-387 Addresses a $2.5 to $4.3 Billion Market for RSV Alone. Anil R. Diwan, PhD, President & Exec. Chairman, NanoViricides, Inc.Dr. Diwan will discuss the revolutionary broad-spectrum antiviral drug candidate NV-387, that is enabled by the nanoviricides technology platform. NV-387 has successfully completed Phase I clinical trial.NV-387 has shown strong antiviral activity, with substantial superiority to existing drugs, against a number of viral diseases in animal models. These include Influenza, RSV, COVID, Influenza, and MPox/Smallpox related animal models.The overall market size for these indications is anticipated to be more than $10 Billion by 2027.For more information about the conference and registration details, please visit Spartan Capital's conference page.The Company has obtained broad, exclusive, sub-licensable, field licenses to drugs developed in several licensed fields from TheraCour Pharma, I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-corporate-spartan-capital-investors-050000186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SPAQ.U","BK4139","BK4211","BK4568","ISBC","NNVC"],"gpt_icon":0},{"id":"2477354153","title":"NanoViricides President Dr. Diwan to Present at the PODD Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2477354153","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477354153?lang=en_us&edition=fundamental","pubTime":"2024-10-22 18:30","pubTimestamp":1729593000,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc.  , a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, will be presenting a talk at the PODD Conference on Monday, October 28th, 2024 at 345pm. The PODD Conference will be held at the Westin Boston Seaport District, MA on October 28 and 29, 2024.The Partnership Opportunities in Drug Delivery  Conference, 2024. Anil R. Diwan, PhD, President & Exec. Chairman, NanoViricides, Inc.Dr. Diwan will then focus on the capabilities of the nanoviricide platform that promise to revolutionize drug delivery to specific cellular targets, to make difficult drugs available orally, and to protect such drugs from bodily metabolism. He will reference the Company's work on encapsulating remdesivir and its prodrugs, ribavirin prodrugs, and others and the improvement in results obtained in animal studies by doing so.The nanoviricides","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-president-dr-diwan-present-103000043.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4551","PODD","BK4139","BK4566","NNVC","BK4585","BK4588","BK4568"],"gpt_icon":0},{"id":"2475957577","title":"NanoViricides President Dr. Diwan Interviwed in PODD Podcast; He Explains the Revolutionary Clinical Stage Broad-Spectrum Antiviral NV-387, and the Potential of the Platform to Revolutionize Fields Beyond Virology","url":"https://stock-news.laohu8.com/highlight/detail?id=2475957577","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475957577?lang=en_us&edition=fundamental","pubTime":"2024-10-15 18:30","pubTimestamp":1728988200,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / October 15, 2024 / NanoViricides, Inc.  , a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, was interviewed in a podcast by the PODD Conference* host. The podcast was published on October 11, 2024, on PharmaTalkRadio.The podcast is also available from the Company's website on the front page .Dr. Diwan explained the nanoviricides technology platform and its potentially revolutionary broad-spectrum antiviral clinical drug candidate NV-387. NV-387 has demonstrated the potential of completely revolutionizing the treatment of viral infections just as penicillin revolutionized the treatment of bacterial infections, based on animal model studies.Dr. Diwan explained that NV-387 is highly unlikely to be escaped by viruses even as they change in the field.More importantly, many drugs show strong effectiveness in early stages of development and then get pus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-president-dr-diwan-interviwed-103000516.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","BK4551","SPB","SSI","BK4018","NNVC","PODD","BK4568","BK4588","BK4178","BK4082","BK4139","BK4023","BK4566","LU2065732104.USD","BK4535","BK4585"],"gpt_icon":1},{"id":"2475988316","title":"NanoViricides Inc. (NNVC): Best Nanotech Penny Stock to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2475988316","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475988316?lang=en_us&edition=fundamental","pubTime":"2024-10-15 01:30","pubTimestamp":1728927040,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the7 Best Nanotech Penny Stocks to Buy.In this article, we are going to take a look at where NanoViricides Inc.  stands against the other the Best Nanotech Penny Stock to Buy.The Federal Reserve’s recent half-point rate cut is expected to benefit small-cap stocks more than large-caps due to their floating-rate debt. Oxford Economics analysts believe small caps could thrive in easier economic conditions and with reduced borrowing costs. Eduardo Lecubarri of J.P. Morgan sees a “generational opportunity” in small to mid-cap stocks, emphasizing the importance of selecting stocks with pricing power and achievable earnings growth. With the economy stabilizing, small to mid-cap stocks offer significant investment potential.Nanotechnology is revolutionizing industries globally, with significant applications in biomedicine, such as novel diagnostic tools, drug delivery systems, and vaccines, driven by rising chronic diseases. It also enhances clean energy through ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/hNtaCSpvhShrvbsn20EXHQ--~B/aD04NTM7dz0xMjc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/b78b6f007ed8b5fe3ce44bcf0723fdec","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/hNtaCSpvhShrvbsn20EXHQ--~B/aD04NTM7dz0xMjc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/b78b6f007ed8b5fe3ce44bcf0723fdec"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-nnvc-best-nanotech-173040178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","LU0225283273.USD","BK4504","LU1989772923.USD","FDN","NNI","LU1162221912.USD","BK4544","LU1989772840.SGD","BK4534","BK4166","BK4585","NANO","BK4588","LU0098860793.USD","BK4568","BK4581","BK4550","LU0106831901.USD","LU0267386448.USD","TINY","LU1720051017.SGD","LU2357305700.SGD","LU1548497426.USD","ARKK","LU1363072403.SGD","BK4127","LU1720051108.HKD","LU1668664300.SGD","LU1074936037.SGD","IE00BKVL7J92.USD","LU0314104364.USD","BK4139","LU0320765646.SGD","LU0971096721.USD","SIMS","IE00BZ1G4Q59.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NNVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-14","symbol":"NNVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-11-14","symbol":"NNVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-09-27","symbol":"NNVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2024-05-14","symbol":"NNVC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-14","symbol":"NNVC","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"post","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NNVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NNVC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NNVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NNVC","date":"2025-04-07","current":-1.803883,"percent":0.869136,"low":-10.944239,"twenty":-4.679953,"median":-2.568302,"eighty":-2.024818,"high":-1.333135,"avg":-3.130965,"sd":1.594638,"marketCap":16892939},"quantilePoints":[{"date":"2020-04-09","current":-5.169165,"twenty":-11.8009,"median":-7.159659,"eighty":-2.578076,"marketCap":40529580},{"date":"2020-04-17","current":-5.055557,"twenty":-11.817856,"median":-7.043222,"eighty":-2.576332,"marketCap":39638820},{"date":"2020-04-24","current":-6.106431,"twenty":-11.817856,"median":-6.98263,"eighty":-2.576332,"marketCap":47878350},{"date":"2020-05-01","current":-5.472119,"twenty":-11.817856,"median":-6.916543,"eighty":-2.576332,"marketCap":42904940},{"date":"2020-05-08","current":-5.964421,"twenty":-11.817856,"median":-6.895192,"eighty":-2.576332,"marketCap":46764900},{"date":"2020-05-15","current":-9.117043,"twenty":-11.817856,"median":-6.898164,"eighty":-2.576332,"marketCap":71483490},{"date":"2020-05-22","current":-8.778349,"twenty":-11.817856,"median":-6.898164,"eighty":-2.576332,"marketCap":68827908},{"date":"2020-05-29","current":-8.720368,"twenty":-11.817856,"median":-6.898164,"eighty":-2.576332,"marketCap":68373298},{"date":"2020-06-05","current":-7.433186,"twenty":-11.733077,"median":-6.898164,"eighty":-2.576332,"marketCap":58280963},{"date":"2020-06-12","current":-7.989805,"twenty":-11.691331,"median":-6.898164,"eighty":-2.576332,"marketCap":62645216},{"date":"2020-06-19","current":-7.653514,"twenty":-11.621323,"median":-6.898164,"eighty":-2.576332,"marketCap":60008480},{"date":"2020-06-26","current":-5.26577,"twenty":-11.551315,"median":-6.837974,"eighty":-2.576332,"marketCap":72584000},{"date":"2020-07-02","current":-4.772104,"twenty":-11.551315,"median":-6.780609,"eighty":-2.576332,"marketCap":65779250},{"date":"2020-07-10","current":-5.742813,"twenty":-11.551315,"median":-6.723707,"eighty":-2.576332,"marketCap":79159607},{"date":"2020-07-17","current":-5.361386,"twenty":-11.551315,"median":-6.669738,"eighty":-2.576332,"marketCap":73901971},{"date":"2020-07-24","current":-4.928766,"twenty":-11.551315,"median":-6.613011,"eighty":-2.576332,"marketCap":67938699},{"date":"2020-07-31","current":-4.820612,"twenty":-11.551315,"median":-6.52606,"eighty":-2.576332,"marketCap":66447881},{"date":"2020-08-07","current":-4.897865,"twenty":-11.551315,"median":-6.500126,"eighty":-2.576332,"marketCap":67512751},{"date":"2020-08-14","current":-4.434345,"twenty":-11.551315,"median":-6.462701,"eighty":-2.576332,"marketCap":61123532},{"date":"2020-08-21","current":-3.74679,"twenty":-11.551315,"median":-6.417575,"eighty":-2.576332,"marketCap":51646190},{"date":"2020-08-28","current":-3.167389,"twenty":-11.551315,"median":-6.399341,"eighty":-2.576332,"marketCap":43659665},{"date":"2020-09-04","current":-3.314171,"twenty":-11.551315,"median":-6.344807,"eighty":-2.576332,"marketCap":45682918},{"date":"2020-09-11","current":-3.059234,"twenty":-11.551315,"median":-6.317369,"eighty":-2.576332,"marketCap":42168848},{"date":"2020-09-18","current":-3.329621,"twenty":-11.551315,"median":-6.266676,"eighty":-2.576332,"marketCap":45895892},{"date":"2020-09-25","current":-2.95108,"twenty":-11.551315,"median":-6.134843,"eighty":-2.576332,"marketCap":40678030},{"date":"2020-10-02","current":-2.958805,"twenty":-11.551315,"median":-6.079026,"eighty":-2.576332,"marketCap":40784517},{"date":"2020-10-09","current":-3.151938,"twenty":-11.551315,"median":-5.961802,"eighty":-2.576332,"marketCap":43446691},{"date":"2020-10-16","current":-3.10436,"twenty":-11.551315,"median":-5.869747,"eighty":-2.576332,"marketCap":41742900},{"date":"2020-10-23","current":-3.088522,"twenty":-11.551315,"median":-5.80821,"eighty":-2.576332,"marketCap":41529926},{"date":"2020-10-30","current":-2.731323,"twenty":-11.551315,"median":-5.763677,"eighty":-2.576332,"marketCap":36726837},{"date":"2020-11-06","current":-2.73924,"twenty":-11.551315,"median":-5.704394,"eighty":-2.576332,"marketCap":36833291},{"date":"2020-11-13","current":-2.778824,"twenty":-11.551315,"median":-5.646071,"eighty":-2.576332,"marketCap":37365564},{"date":"2020-11-20","current":-2.817128,"twenty":-11.551315,"median":-5.55316,"eighty":-2.576332,"marketCap":39993750},{"date":"2020-11-27","current":-2.704443,"twenty":-11.551315,"median":-5.550142,"eighty":-2.576332,"marketCap":38394000},{"date":"2020-12-04","current":-2.907276,"twenty":-11.551315,"median":-5.479283,"eighty":-2.576332,"marketCap":41273550},{"date":"2020-12-11","current":-2.606783,"twenty":-11.551315,"median":-5.436362,"eighty":-2.576332,"marketCap":37007550},{"date":"2020-12-18","current":-2.636832,"twenty":-11.551315,"median":-5.410581,"eighty":-2.576332,"marketCap":37434150},{"date":"2020-12-24","current":-2.636832,"twenty":-11.551315,"median":-5.369111,"eighty":-2.576332,"marketCap":37434150},{"date":"2020-12-31","current":-2.156042,"twenty":-11.481307,"median":-5.329042,"eighty":-2.551389,"marketCap":30608550},{"date":"2021-01-08","current":-2.464048,"twenty":-11.481307,"median":-5.269538,"eighty":-2.537233,"marketCap":34981200},{"date":"2021-01-15","current":-2.464048,"twenty":-11.481307,"median":-5.232807,"eighty":-2.519791,"marketCap":34981200},{"date":"2021-01-22","current":-3.327968,"twenty":-11.481307,"median":-5.222018,"eighty":-2.519791,"marketCap":47245950},{"date":"2021-01-29","current":-3.034986,"twenty":-11.481307,"median":-5.155523,"eighty":-2.519791,"marketCap":43086600},{"date":"2021-02-05","current":-3.538313,"twenty":-11.4113,"median":-5.109511,"eighty":-2.519791,"marketCap":50232150},{"date":"2021-02-12","current":-3.78622,"twenty":-11.341292,"median":-5.07155,"eighty":-2.519791,"marketCap":53751600},{"date":"2021-02-19","current":-3.620149,"twenty":-11.311529,"median":-5.024525,"eighty":-2.519791,"marketCap":52851150},{"date":"2021-02-26","current":-3.057014,"twenty":-11.271284,"median":-5.00388,"eighty":-2.519791,"marketCap":44629860},{"date":"2021-03-05","current":-3.876119,"twenty":-11.177066,"median":-4.973773,"eighty":-2.518657,"marketCap":56588100},{"date":"2021-03-12","current":-3.817611,"twenty":-11.075262,"median":-4.952574,"eighty":-2.518657,"marketCap":55733940},{"date":"2021-03-19","current":-3.678656,"twenty":-10.947439,"median":-4.928766,"eighty":-2.518657,"marketCap":53705310},{"date":"2021-03-26","current":-3.605522,"twenty":-10.921244,"median":-4.89353,"eighty":-2.519791,"marketCap":52637610},{"date":"2021-04-01","current":-3.47388,"twenty":-10.851236,"median":-4.872521,"eighty":-2.519791,"marketCap":50715750},{"date":"2021-04-09","current":-3.408059,"twenty":-10.781228,"median":-4.831249,"eighty":-2.518657,"marketCap":49754820},{"date":"2021-04-16","current":-3.00582,"twenty":-10.596948,"median":-4.785979,"eighty":-2.518657,"marketCap":43882470},{"date":"2021-04-23","current":-3.057014,"twenty":-10.508695,"median":-4.726099,"eighty":-2.518657,"marketCap":44629860},{"date":"2021-04-30","current":-3.035074,"twenty":-10.404778,"median":-4.666105,"eighty":-2.518657,"marketCap":44309550},{"date":"2021-05-07","current":-2.654776,"twenty":-9.700722,"median":-4.544321,"eighty":-2.518657,"marketCap":38757510},{"date":"2021-05-14","current":-4.562569,"twenty":-9.419194,"median":-4.510132,"eighty":-2.506117,"marketCap":39347100},{"date":"2021-05-21","current":-4.776022,"twenty":-9.231528,"median":-4.510132,"eighty":-2.506117,"marketCap":41187900},{"date":"2021-05-28","current":-4.789363,"twenty":-9.074029,"median":-4.510132,"eighty":-2.506117,"marketCap":41302950},{"date":"2021-06-04","current":-5.002817,"twenty":-9.026854,"median":-4.518582,"eighty":-2.509122,"marketCap":43143750},{"date":"2021-06-11","current":-5.883312,"twenty":-8.963729,"median":-4.518582,"eighty":-2.509122,"marketCap":50737050},{"date":"2021-06-18","current":-5.082862,"twenty":-8.899973,"median":-4.518582,"eighty":-2.509122,"marketCap":43834050},{"date":"2021-06-25","current":-6.216833,"twenty":-8.83748,"median":-4.518582,"eighty":-2.509122,"marketCap":53613300},{"date":"2021-07-02","current":-5.736563,"twenty":-8.774355,"median":-4.518582,"eighty":-2.509122,"marketCap":49471500},{"date":"2021-07-09","current":-5.576473,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":48090900},{"date":"2021-07-16","current":-5.242952,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":45214650},{"date":"2021-07-23","current":-5.656518,"twenty":-8.672078,"median":-4.518582,"eighty":-2.509122,"marketCap":48781200},{"date":"2021-07-30","current":-5.363019,"twenty":-8.648105,"median":-4.518582,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-08-06","current":-5.21627,"twenty":-8.605807,"median":-4.518582,"eighty":-2.509122,"marketCap":44984550},{"date":"2021-08-13","current":-5.069521,"twenty":-8.58498,"median":-4.518582,"eighty":-2.509122,"marketCap":43719000},{"date":"2021-08-20","current":-4.949453,"twenty":-8.521855,"median":-4.518582,"eighty":-2.509122,"marketCap":42683550},{"date":"2021-08-27","current":-5.136225,"twenty":-8.381184,"median":-4.527033,"eighty":-2.509122,"marketCap":44294250},{"date":"2021-09-03","current":-5.363019,"twenty":-8.332481,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-10","current":-5.256293,"twenty":-8.269356,"median":-4.527335,"eighty":-2.509122,"marketCap":45329700},{"date":"2021-09-17","current":-5.363019,"twenty":-8.206231,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-24","current":-6.777149,"twenty":-8.180981,"median":-4.527335,"eighty":-2.509122,"marketCap":58445400},{"date":"2021-10-01","current":-5.869971,"twenty":-8.079981,"median":-4.527335,"eighty":-2.509122,"marketCap":50622000},{"date":"2021-10-08","current":-5.829949,"twenty":-8.016857,"median":-4.527335,"eighty":-2.509122,"marketCap":50276850},{"date":"2021-10-15","current":-6.36953,"twenty":-8.010675,"median":-4.527335,"eighty":-2.509122,"marketCap":56193200},{"date":"2021-10-22","current":-6.304269,"twenty":-7.953732,"median":-4.527335,"eighty":-2.509122,"marketCap":55617450},{"date":"2021-10-29","current":-6.186798,"twenty":-7.94329,"median":-4.527335,"eighty":-2.509122,"marketCap":54581100},{"date":"2021-11-05","current":-6.173746,"twenty":-7.890607,"median":-4.527335,"eighty":-2.509122,"marketCap":54465950},{"date":"2021-11-12","current":-6.095432,"twenty":-7.788302,"median":-4.527335,"eighty":-2.509122,"marketCap":53775050},{"date":"2021-11-19","current":-5.797853,"twenty":-7.663997,"median":-4.527335,"eighty":-2.509122,"marketCap":52899750},{"date":"2021-11-26","current":-6.138903,"twenty":-7.585674,"median":-4.527335,"eighty":-2.509122,"marketCap":56011500},{"date":"2021-12-03","current":-5.633644,"twenty":-7.428051,"median":-4.527335,"eighty":-2.509122,"marketCap":51401500},{"date":"2021-12-10","current":-5.406277,"twenty":-7.300703,"median":-4.527335,"eighty":-2.509122,"marketCap":49327000},{"date":"2021-12-17","current":-5.229436,"twenty":-7.180968,"median":-4.527335,"eighty":-2.509122,"marketCap":47713500},{"date":"2021-12-23","current":-4.976806,"twenty":-7.079181,"median":-4.527335,"eighty":-2.509122,"marketCap":45408500},{"date":"2021-12-31","current":-4.698914,"twenty":-6.987904,"median":-4.527335,"eighty":-2.509122,"marketCap":42873000},{"date":"2022-01-07","current":-3.890498,"twenty":-6.926651,"median":-4.436412,"eighty":-2.509122,"marketCap":35497000},{"date":"2022-01-14","current":-3.675763,"twenty":-6.89782,"median":-4.401483,"eighty":-2.509122,"marketCap":33537750},{"date":"2022-01-21","current":-2.905242,"twenty":-6.846702,"median":-4.310739,"eighty":-2.509122,"marketCap":26507500},{"date":"2022-01-28","current":-2.728401,"twenty":-6.779582,"median":-4.173405,"eighty":-2.509122,"marketCap":24894000},{"date":"2022-02-04","current":-3.05682,"twenty":-6.712109,"median":-4.02803,"eighty":-2.509122,"marketCap":27890500},{"date":"2022-02-11","current":-2.854716,"twenty":-6.637806,"median":-3.995999,"eighty":-2.509122,"marketCap":26046500},{"date":"2022-02-18","current":-2.62043,"twenty":-6.580578,"median":-3.946834,"eighty":-2.509122,"marketCap":22837320},{"date":"2022-02-25","current":-2.646899,"twenty":-6.52606,"median":-3.923893,"eighty":-2.509122,"marketCap":23068000},{"date":"2022-03-04","current":-2.50132,"twenty":-6.496806,"median":-3.868397,"eighty":-2.507562,"marketCap":21799260},{"date":"2022-03-11","current":-2.448382,"twenty":-6.462701,"median":-3.821268,"eighty":-2.492597,"marketCap":21337900},{"date":"2022-03-18","current":-2.964527,"twenty":-6.435992,"median":-3.787617,"eighty":-2.484025,"marketCap":25836160},{"date":"2022-03-25","current":-3.096872,"twenty":-6.399341,"median":-3.766488,"eighty":-2.484025,"marketCap":26989560},{"date":"2022-04-01","current":-2.73954,"twenty":-6.395635,"median":-3.735019,"eighty":-2.484025,"marketCap":23875380},{"date":"2022-04-08","current":-2.593961,"twenty":-6.356646,"median":-3.703835,"eighty":-2.484025,"marketCap":22606640},{"date":"2022-04-14","current":-2.501584,"twenty":-6.335311,"median":-3.656716,"eighty":-2.482663,"marketCap":21801566},{"date":"2022-04-22","current":-2.223395,"twenty":-6.304269,"median":-3.638432,"eighty":-2.478152,"marketCap":19377120},{"date":"2022-04-29","current":-1.97194,"twenty":-6.279718,"median":-3.579246,"eighty":-2.47116,"marketCap":17185660},{"date":"2022-05-06","current":-1.97194,"twenty":-6.219501,"median":-3.523708,"eighty":-2.460477,"marketCap":17185660},{"date":"2022-05-13","current":-1.710426,"twenty":-6.176384,"median":-3.477537,"eighty":-2.45259,"marketCap":14906541},{"date":"2022-05-20","current":-3.57635,"twenty":-6.112925,"median":-3.448283,"eighty":-2.44683,"marketCap":30040400},{"date":"2022-05-27","current":-2.957366,"twenty":-6.0948,"median":-3.404402,"eighty":-2.44683,"marketCap":24841100},{"date":"2022-06-03","current":-2.751038,"twenty":-6.063146,"median":-3.382022,"eighty":-2.44683,"marketCap":23108000},{"date":"2022-06-10","current":-2.778549,"twenty":-6.021887,"median":-3.36235,"eighty":-2.44683,"marketCap":23339080},{"date":"2022-06-17","current":-2.764793,"twenty":-5.978029,"median":-3.327968,"eighty":-2.44683,"marketCap":23223540},{"date":"2022-06-24","current":-2.806059,"twenty":-5.953332,"median":-3.30945,"eighty":-2.445278,"marketCap":23570160},{"date":"2022-07-01","current":-2.599731,"twenty":-5.898451,"median":-3.23985,"eighty":-2.445278,"marketCap":21837060},{"date":"2022-07-08","current":-3.148563,"twenty":-5.871439,"median":-3.219656,"eighty":-2.445278,"marketCap":26447106},{"date":"2022-07-15","current":-2.737283,"twenty":-5.837732,"median":-3.192745,"eighty":-2.445278,"marketCap":22992460},{"date":"2022-07-22","current":-2.874835,"twenty":-5.807263,"median":-3.167389,"eighty":-2.445278,"marketCap":24147860},{"date":"2022-07-29","current":-2.503445,"twenty":-5.78537,"median":-3.144776,"eighty":-2.440257,"marketCap":21028280},{"date":"2022-08-05","current":-4.869338,"twenty":-5.744619,"median":-3.132647,"eighty":-2.440257,"marketCap":40901160},{"date":"2022-08-12","current":-3.823943,"twenty":-5.727928,"median":-3.132647,"eighty":-2.440257,"marketCap":32120120},{"date":"2022-08-19","current":-3.342511,"twenty":-5.684312,"median":-3.132647,"eighty":-2.440257,"marketCap":28076220},{"date":"2022-08-26","current":-3.094918,"twenty":-5.661854,"median":-3.132245,"eighty":-2.440257,"marketCap":25996500},{"date":"2022-09-02","current":-2.902345,"twenty":-5.581809,"median":-3.128118,"eighty":-2.440257,"marketCap":24378940},{"date":"2022-09-09","current":-2.984876,"twenty":-5.560806,"median":-3.117013,"eighty":-2.440257,"marketCap":25072180},{"date":"2022-09-16","current":-2.668507,"twenty":-5.55316,"median":-3.10436,"eighty":-2.440257,"marketCap":22414760},{"date":"2022-09-23","current":-2.14581,"twenty":-5.519162,"median":-3.095823,"eighty":-2.439684,"marketCap":18024240},{"date":"2022-09-30","current":-2.379648,"twenty":-5.477266,"median":-3.088522,"eighty":-2.439647,"marketCap":19988420},{"date":"2022-10-07","current":-2.132055,"twenty":-5.456405,"median":-3.080603,"eighty":-2.439647,"marketCap":17908700},{"date":"2022-10-14","current":-2.502362,"twenty":-5.43594,"median":-3.072683,"eighty":-2.437394,"marketCap":20286302},{"date":"2022-10-21","current":-2.402267,"twenty":-5.421719,"median":-3.06696,"eighty":-2.434784,"marketCap":19474850},{"date":"2022-10-28","current":-2.359369,"twenty":-5.377446,"median":-3.06013,"eighty":-2.430342,"marketCap":19127085},{"date":"2022-11-04","current":-2.334363,"twenty":-5.363019,"median":-3.057014,"eighty":-2.4206,"marketCap":18924360},{"date":"2022-11-11","current":-2.477575,"twenty":-5.336338,"median":-3.043934,"eighty":-2.417533,"marketCap":20085364},{"date":"2022-11-18","current":-2.711681,"twenty":-5.332826,"median":-3.036058,"eighty":-2.417533,"marketCap":19156500},{"date":"2022-11-25","current":-2.760984,"twenty":-5.332826,"median":-3.034986,"eighty":-2.417533,"marketCap":19504800},{"date":"2022-12-02","current":-2.777419,"twenty":-5.332826,"median":-3.028333,"eighty":-2.417533,"marketCap":19620900},{"date":"2022-12-09","current":-2.39121,"twenty":-5.292381,"median":-3.026142,"eighty":-2.416192,"marketCap":16892550},{"date":"2022-12-16","current":-2.087173,"twenty":-5.292381,"median":-3.018926,"eighty":-2.406742,"marketCap":14744700},{"date":"2022-12-23","current":-1.972132,"twenty":-5.292381,"median":-3.00582,"eighty":-2.395506,"marketCap":13932000},{"date":"2022-12-30","current":-1.824222,"twenty":-5.292381,"median":-2.997432,"eighty":-2.389879,"marketCap":12887100},{"date":"2023-01-06","current":-2.202214,"twenty":-5.277173,"median":-2.989706,"eighty":-2.387968,"marketCap":15557400},{"date":"2023-01-13","current":-2.333853,"twenty":-5.260084,"median":-2.981981,"eighty":-2.376115,"marketCap":16487361},{"date":"2023-01-20","current":-2.30082,"twenty":-5.250996,"median":-2.973783,"eighty":-2.373517,"marketCap":16254000},{"date":"2023-01-27","current":-2.399427,"twenty":-5.240028,"median":-2.96653,"eighty":-2.370947,"marketCap":16950600},{"date":"2023-02-03","current":-2.284386,"twenty":-5.221675,"median":-2.956693,"eighty":-2.366583,"marketCap":16137900},{"date":"2023-02-10","current":-2.276169,"twenty":-5.202929,"median":-2.950137,"eighty":-2.360695,"marketCap":16079850},{"date":"2023-02-17","current":-2.44914,"twenty":-5.171998,"median":-2.943354,"eighty":-2.359369,"marketCap":16870750},{"date":"2023-02-24","current":-2.128219,"twenty":-5.154465,"median":-2.937326,"eighty":-2.348627,"marketCap":14660100},{"date":"2023-03-03","current":-2.330906,"twenty":-5.122989,"median":-2.92765,"eighty":-2.343232,"marketCap":16056300},{"date":"2023-03-10","current":-2.145109,"twenty":-5.087088,"median":-2.913716,"eighty":-2.342061,"marketCap":14776450},{"date":"2023-03-17","current":-2.195781,"twenty":-5.05618,"median":-2.905242,"eighty":-2.334159,"marketCap":15125500},{"date":"2023-03-24","current":-2.094437,"twenty":-5.017952,"median":-2.902345,"eighty":-2.329408,"marketCap":14427400},{"date":"2023-03-31","current":-1.97975,"twenty":-5.017055,"median":-2.891819,"eighty":-2.325041,"marketCap":13637383},{"date":"2023-04-06","current":-2.753172,"twenty":-5.017055,"median":-2.888698,"eighty":-2.322276,"marketCap":18965050},{"date":"2023-04-14","current":-1.993094,"twenty":-5.017952,"median":-2.874835,"eighty":-2.316037,"marketCap":13729300},{"date":"2023-04-21","current":-2.263344,"twenty":-5.002368,"median":-2.859591,"eighty":-2.313801,"marketCap":15590900},{"date":"2023-04-28","current":-2.280234,"twenty":-5.002368,"median":-2.849614,"eighty":-2.312786,"marketCap":15707250},{"date":"2023-05-05","current":-2.077547,"twenty":-5.002368,"median":-2.840873,"eighty":-2.302937,"marketCap":14311050},{"date":"2023-05-11","current":-2.043766,"twenty":-5.002368,"median":-2.835777,"eighty":-2.30082,"marketCap":14078350},{"date":"2023-05-19","current":-1.920317,"twenty":-5.002518,"median":-2.832097,"eighty":-2.294808,"marketCap":13055420},{"date":"2023-05-26","current":-1.887542,"twenty":-5.002667,"median":-2.817128,"eighty":-2.284962,"marketCap":12832600},{"date":"2023-06-02","current":-2.239311,"twenty":-5.002667,"median":-2.810544,"eighty":-2.283362,"marketCap":15224130},{"date":"2023-06-09","current":-1.973339,"twenty":-5.002817,"median":-2.806059,"eighty":-2.276679,"marketCap":13415900},{"date":"2023-06-16","current":-1.870383,"twenty":-5.008153,"median":-2.792391,"eighty":-2.269675,"marketCap":12715940},{"date":"2023-06-23","current":-1.921861,"twenty":-5.010821,"median":-2.779567,"eighty":-2.263344,"marketCap":13065920},{"date":"2023-06-30","current":-2.144934,"twenty":-5.017055,"median":-2.778549,"eighty":-2.263295,"marketCap":14582500},{"date":"2023-07-06","current":-2.024818,"twenty":-5.017952,"median":-2.777419,"eighty":-2.259272,"marketCap":13765880},{"date":"2023-07-14","current":-2.488124,"twenty":-5.020645,"median":-2.769833,"eighty":-2.254292,"marketCap":16915700},{"date":"2023-07-21","current":-2.745516,"twenty":-5.0361,"median":-2.767019,"eighty":-2.252684,"marketCap":18665600},{"date":"2023-07-27","current":-2.676878,"twenty":-5.039964,"median":-2.764793,"eighty":-2.252282,"marketCap":18198960},{"date":"2023-08-04","current":-2.453805,"twenty":-5.039964,"median":-2.753964,"eighty":-2.252129,"marketCap":16682380},{"date":"2023-08-11","current":-2.219738,"twenty":-5.039964,"median":-2.751307,"eighty":-2.246058,"marketCap":15091061},{"date":"2023-08-18","current":-2.21991,"twenty":-5.039964,"median":-2.751307,"eighty":-2.244476,"marketCap":15092230},{"date":"2023-08-25","current":-2.667127,"twenty":-5.039964,"median":-2.753168,"eighty":-2.251186,"marketCap":18132670},{"date":"2023-09-01","current":-2.495054,"twenty":-5.039964,"median":-2.751038,"eighty":-2.251186,"marketCap":16962820},{"date":"2023-09-08","current":-2.340189,"twenty":-5.039964,"median":-2.74376,"eighty":-2.251186,"marketCap":15909955},{"date":"2023-09-15","current":-2.288567,"twenty":-5.039964,"median":-2.738088,"eighty":-2.246453,"marketCap":15559001},{"date":"2023-09-22","current":-2.185324,"twenty":-5.039964,"median":-2.725967,"eighty":-2.236945,"marketCap":14857091},{"date":"2023-09-29","current":-2.426225,"twenty":-5.039964,"median":-2.723609,"eighty":-2.236573,"marketCap":16494880},{"date":"2023-10-06","current":-2.254153,"twenty":-5.039964,"median":-2.723609,"eighty":-2.234464,"marketCap":15325031},{"date":"2023-10-13","current":-2.013251,"twenty":-5.039964,"median":-2.723467,"eighty":-2.230216,"marketCap":13687241},{"date":"2023-10-20","current":-1.572776,"twenty":-5.039964,"median":-2.723467,"eighty":-2.222732,"marketCap":13507900},{"date":"2023-10-27","current":-1.600128,"twenty":-5.039964,"median":-2.72369,"eighty":-2.219772,"marketCap":13742820},{"date":"2023-11-03","current":-1.5591,"twenty":-5.039964,"median":-2.72369,"eighty":-2.211571,"marketCap":13390440},{"date":"2023-11-10","current":-1.463365,"twenty":-5.039964,"median":-2.718749,"eighty":-2.202243,"marketCap":12568220},{"date":"2023-11-17","current":-1.487026,"twenty":-5.039964,"median":-2.715489,"eighty":-2.195907,"marketCap":13363424},{"date":"2023-11-24","current":-1.359275,"twenty":-5.039964,"median":-2.713071,"eighty":-2.189723,"marketCap":12215368},{"date":"2023-12-01","current":-1.503045,"twenty":-5.039964,"median":-2.709773,"eighty":-2.185324,"marketCap":13507379},{"date":"2023-12-08","current":-1.50958,"twenty":-5.039964,"median":-2.70214,"eighty":-2.168223,"marketCap":13566106},{"date":"2023-12-15","current":-1.489975,"twenty":-5.039964,"median":-2.696474,"eighty":-2.162,"marketCap":13389923},{"date":"2023-12-22","current":-1.385415,"twenty":-5.039964,"median":-2.696474,"eighty":-2.156514,"marketCap":12450279},{"date":"2023-12-29","current":-1.398485,"twenty":-5.039964,"median":-2.696931,"eighty":-2.156278,"marketCap":12567735},{"date":"2024-01-05","current":-1.424625,"twenty":-5.039964,"median":-2.698293,"eighty":-2.150909,"marketCap":12802646},{"date":"2024-01-12","current":-1.353525,"twenty":-5.039964,"median":-2.698293,"eighty":-2.145109,"marketCap":12163688},{"date":"2024-01-19","current":-1.359275,"twenty":-5.043083,"median":-2.699655,"eighty":-2.135592,"marketCap":12215368},{"date":"2024-01-26","current":-1.385415,"twenty":-5.039964,"median":-2.698293,"eighty":-2.120042,"marketCap":12450279},{"date":"2024-02-02","current":-1.476905,"twenty":-5.039964,"median":-2.698293,"eighty":-2.111328,"marketCap":13272468},{"date":"2024-02-09","current":-1.516115,"twenty":-5.039964,"median":-2.687524,"eighty":-2.094437,"marketCap":13624834},{"date":"2024-02-16","current":-1.498107,"twenty":-5.039964,"median":-2.682084,"eighty":-2.081184,"marketCap":14017010},{"date":"2024-02-23","current":-1.59882,"twenty":-5.039964,"median":-2.676392,"eighty":-2.064581,"marketCap":14959330},{"date":"2024-03-01","current":-1.699533,"twenty":-5.0361,"median":-2.668507,"eighty":-2.049674,"marketCap":15901650},{"date":"2024-03-08","current":-1.422572,"twenty":-5.0361,"median":-2.666881,"eighty":-2.03312,"marketCap":13310270},{"date":"2024-03-15","current":-1.472929,"twenty":-5.0361,"median":-2.656354,"eighty":-2.014962,"marketCap":13781430},{"date":"2024-03-22","current":-1.435162,"twenty":-5.0361,"median":-2.651857,"eighty":-1.997134,"marketCap":13428060},{"date":"2024-03-28","current":-1.422572,"twenty":-5.0361,"median":-2.646899,"eighty":-1.988953,"marketCap":13310270},{"date":"2024-04-05","current":-1.724712,"twenty":-5.039964,"median":-2.645782,"eighty":-1.976203,"marketCap":16137230},{"date":"2024-04-12","current":-1.59882,"twenty":-5.039964,"median":-2.640997,"eighty":-1.967997,"marketCap":14959330},{"date":"2024-04-19","current":-1.479223,"twenty":-5.039964,"median":-2.636576,"eighty":-1.942422,"marketCap":13840325},{"date":"2024-04-26","current":-1.397394,"twenty":-5.0361,"median":-2.625126,"eighty":-1.921861,"marketCap":13074690},{"date":"2024-05-03","current":-1.510696,"twenty":-5.0361,"median":-2.62043,"eighty":-1.908491,"marketCap":14134800},{"date":"2024-05-10","current":-2.303812,"twenty":-5.0361,"median":-2.62043,"eighty":-1.904702,"marketCap":21555570},{"date":"2024-05-17","current":-2.762595,"twenty":-5.0361,"median":-2.63632,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-24","current":-2.762595,"twenty":-5.0361,"median":-2.640997,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-31","current":-3.010361,"twenty":-5.0361,"median":-2.645943,"eighty":-1.904702,"marketCap":28622970},{"date":"2024-06-07","current":-3.282904,"twenty":-5.0361,"median":-2.651857,"eighty":-1.904702,"marketCap":31214350},{"date":"2024-06-14","current":-3.205683,"twenty":-5.039964,"median":-2.663299,"eighty":-1.904702,"marketCap":30480120},{"date":"2024-06-21","current":-2.522301,"twenty":-5.039964,"median":-2.666881,"eighty":-1.904582,"marketCap":23982420},{"date":"2024-06-28","current":-2.149547,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20438220},{"date":"2024-07-05","current":-2.186822,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20792640},{"date":"2024-07-12","current":-2.236523,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":21265200},{"date":"2024-07-15","current":-2.161972,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20556360},{"date":"2024-08-02","current":-2.609277,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":24809400},{"date":"2024-08-09","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-16","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-23","current":-2.286223,"twenty":-5.05618,"median":-2.675731,"eighty":-1.887542,"marketCap":21737760},{"date":"2024-08-30","current":-2.335924,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":22210320},{"date":"2024-09-06","current":-2.224098,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":21147060},{"date":"2024-09-13","current":-2.087421,"twenty":-5.05618,"median":-2.675731,"eighty":-1.899521,"marketCap":19847520},{"date":"2024-09-20","current":-1.96317,"twenty":-5.05618,"median":-2.675731,"eighty":-1.917578,"marketCap":18666120},{"date":"2024-09-27","current":-1.764368,"twenty":-5.05618,"median":-2.675731,"eighty":-1.921243,"marketCap":16775880},{"date":"2024-10-04","current":-2.008373,"twenty":-5.05618,"median":-2.675731,"eighty":-1.947416,"marketCap":16657740},{"date":"2024-10-11","current":-1.951398,"twenty":-5.05618,"median":-2.675731,"eighty":-1.961627,"marketCap":16185180},{"date":"2024-10-18","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.972856,"marketCap":17602860},{"date":"2024-10-25","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.978331,"marketCap":17602860},{"date":"2024-10-31","current":-1.937154,"twenty":-5.05618,"median":-2.675731,"eighty":-1.988348,"marketCap":16067040},{"date":"2024-11-08","current":-2.122323,"twenty":-5.05618,"median":-2.675818,"eighty":-2.003331,"marketCap":17602860},{"date":"2024-11-15","current":-1.908667,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15830760},{"date":"2024-11-22","current":-1.599829,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15121920},{"date":"2024-11-29","current":-2.06427,"twenty":-5.05618,"median":-2.675818,"eighty":-2.022617,"marketCap":19511920},{"date":"2024-12-06","current":-2.216055,"twenty":-5.05618,"median":-2.675818,"eighty":-2.028308,"marketCap":20946620},{"date":"2024-12-13","current":-2.231234,"twenty":-5.05618,"median":-2.675818,"eighty":-2.043766,"marketCap":21090090},{"date":"2024-12-20","current":-2.200877,"twenty":-5.05618,"median":-2.675818,"eighty":-2.051201,"marketCap":20803150},{"date":"2024-12-27","current":-2.291947,"twenty":-5.05618,"median":-2.675818,"eighty":-2.063251,"marketCap":21663970},{"date":"2025-01-03","current":-2.155341,"twenty":-5.05618,"median":-2.675818,"eighty":-2.067504,"marketCap":20372740},{"date":"2025-01-10","current":-2.109806,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":19942330},{"date":"2025-01-17","current":-1.821415,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":17216400},{"date":"2025-01-24","current":-1.699987,"twenty":-5.05618,"median":-2.675731,"eighty":-2.077956,"marketCap":16068640},{"date":"2025-01-31","current":-1.624095,"twenty":-5.019747,"median":-2.668507,"eighty":-2.064332,"marketCap":15351290},{"date":"2025-02-07","current":-1.86695,"twenty":-4.974978,"median":-2.666881,"eighty":-2.051347,"marketCap":17646810},{"date":"2025-02-14","current":-1.958021,"twenty":-4.948211,"median":-2.651857,"eighty":-2.049178,"marketCap":18507630},{"date":"2025-02-21","current":-2.42188,"twenty":-4.923399,"median":-2.645943,"eighty":-2.049178,"marketCap":22680335},{"date":"2025-02-28","current":-2.238151,"twenty":-4.869408,"median":-2.636832,"eighty":-2.049178,"marketCap":20959758},{"date":"2025-03-07","current":-2.204746,"twenty":-4.859238,"median":-2.619088,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-14","current":-2.021017,"twenty":-4.814317,"median":-2.611175,"eighty":-2.043766,"marketCap":18926349},{"date":"2025-03-21","current":-2.204746,"twenty":-4.762681,"median":-2.603257,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-28","current":-2.021017,"twenty":-4.736,"median":-2.593961,"eighty":-2.037721,"marketCap":18926349},{"date":"2025-04-04","current":-1.904099,"twenty":-4.695977,"median":-2.574477,"eighty":-2.024878,"marketCap":17831436},{"date":"2025-04-07","current":-1.803883,"twenty":-4.679953,"median":-2.568302,"eighty":-2.024818,"marketCap":16892939}],"updateTime":1744155021243}}}